¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"flux ratio method"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • dextrose-nitrogen ratio
    Æ÷µµ´çÁú¼Òºñ
  • dilution ratio
    Èñ¼®ºñ
  • disease odds ratio
    Áúº´±³Â÷ºñ, Áúº´½Â»êºñ
  • distribution ratio
    ºÐÆ÷ºñÀ²
  • exposure ratio
    ³ëÃâºñÀ²
  • exposure-odds ratio
    ³ëÃâ±³Â÷ºñ
  • extraction ratio
    ÃßÃâ·ü
  • fetal death ratio
    žƻç¸Áºñ
  • gyromagnetic ratio
    ÀÚ±âȸÀüºñ
  • gas exchange ratio
    °¡½º±³È¯ºñÀ²
  • heart lung ratio
    ½ÉÆóºñ
  • hydrodynamic ratio
    ¼ö·ÂÇкñÀ², À¯Ã¼¿ªÇкñÀ²
  • inverse-ratio ventilation
    ¿ªºñȯ±â
  • innervation ratio
    ½Å°æÁö¹èºñ
  • inspiratory expiratory ratio
    µé¼û³¯¼ûºñÀ², Èí±âÈ£±âºñÀ²
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • curative ratio
    Ä¡À¯ºñ
  • dependency ratio
    ºÎ¾çºñ
  • depth to width ratio
    ±íÀÌÆøºñÀ²
  • dextrose-nitrogen ratio
    Æ÷µµ´çÁú¼Òºñ
  • dilution ratio
    ¹±Èûºñ, Èñ¼®ºñ
  • disease odds ratio
    Áúº´±³Â÷ºñ
  • distribution ratio
    ºÐÆ÷ºñÀ²
  • exposure ratio
    ³ëÃâºñÀ²
  • exposure-odds ratio
    ³ëÃâ±³Â÷ºñ
  • extraction ratio
    ÃßÃâ·ü
  • ratio estimate
    ºñÀ²ÃßÁ¤°ª
  • fetal death ratio
    žƻç¸Áºñ
  • gas exchange ratio
    °¡½º±³È¯ºñÀ²
  • gyromagnetic ratio
    ȸÀüÀÚ±âºñÀ²
  • heart lung ratio
    ½ÉÆó°è¼ö, ½ÉÀåÈä°ûºñ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • phase ratio
    »óºñ(ßÓÝï).
  • primary sex ratio
    ÀÏÂ÷¼º ºñ(ÊÙËÛËÓ).
  • ratio
    ºñ(ËÓ).
  • ratio
    ºñ(Ýï)
  • ratio estimate
    ºñÃßÁ¤·®(ËÓÌ§ËøËâ).
  • ratio intelligence qoutient
    Áö´ÉºñÀ²Áö¼ö
  • ratio of accommodative convergence to accommodation
    Á¶ÀýÆøÁÖºñ
  • ratio of dependants
    ºÎ¾çºñ(ËÓËâËÓ).
  • Abell-Kendal method
    ¾Æº§-ÄË´Þ(¹æ)¹ý
  • Brown method
    ºê¶ó¿î¹æ¹ý
  • Callianos method (of artificial respiration)
    Ä®¸®¾Æ³ë ÀΰøÈ£Èí¹ý.
  • Carrels method
    Ä«·¼¹ý.
  • Castaigne method
    Ä«½ºÅ¸Àιý.
  • Castanedas rat lung method
    Ä«½ºÅ¸³×´Ù ¼­Æó¹ý.
  • Cathelins method
    Ä«ÅÚ¶õ¹ý.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • cardiothoracic ratio
    ½ÉÈäºñ(ãýýØÝï)
  • cardiothoraxic ratio
    ½ÉÈäºñ.ÈäºÎ½ÉÈä°ûºñ, ½ÉÆó°è¼ö(ãýøËÌõâ¦).
  • cell color ratio
    (Àû)Ç÷±¸»ö¼Òºñ.
  • charge-to mass ratio
    ÀüÇÏ´ëÁú·®ºñ
  • child woman ratio
    ¸ð¾ÆºñÀ²(ËÎËâËÓËô).
  • common ratio
    °øºñ(ÍëÝï)
  • common ratio
    °øºñ(Ë­ËÓ).
  • contrast enhancement ratio
    Á¶¿µ Áõ°­ºñ
  • contrast to noise ratio
    ´ëÁ¶ ÀâÀ½ºñ
  • correlation ratio
    »ó°üºñ(Ë×Ë´ËÓ).
  • cup-disc ratio
    À¯µÎÇÔ¸ôºñ
  • curative ratio
    Ä¡À¯À²(̬Ëô ).
  • depth to width ratio
    ±íÀÌ Æø ºñÀ²
  • dilution ratio
    ¹±Èûºñ(¡­Ýï), Èñ¼®ºñ.
  • distribution ratio
    ºÐÆ÷ºñÀ²
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • polarity ratio
    ±Ø¼º ºñÀ²(пàõÝï×Ë)
  • P:O ratio
    P/O ºñ
  • protein efficiency ratio
    ´Ü¹éÁú(Ó±ÛÜòõ) È¿À²ºñ(üù×ËÝï)
  • signal-to-noise ratio
    ½ÅÈ£/ÀâÀ½ºñ(ãáûÜ/íÚëåÝï)
  • viscosity ratio
    Á¡µµÀ²(ïÄÓøëÒ)
  • agar diffusion method
    ÇÑõȮ»ê¹ý(ùÎô¸üªß¤Ûö)
  • amyloclastic method
    ¾Æ¹Ð·ÎºÐÇØ¹ý(ÝÂú°Ûö)
  • amylometric method
    "¾Æ¹Ð·ÎÀ̵åÃøÁ¤¹ý(ö´ïÒÛö), ¾Æ¹Ð·ÎÀ̵å¹ý(Ûö)"
  • analytical method
    ºÐ¼®¹ý(ÝÂà°Ûö)
  • antiglobulin method
    Ç×(ù÷)±Û·ÎºÒ¸° ¹æ¹ý(Û°Ûö)
  • Archibald method
    ¾ÆÄ¡¹ßµå¹ý(Ûö)
  • Astrtup method
    ¾Æ½ºÆ®·´¹ý(Ûö)
  • auxanographic method
    ¿Á»ç³ë±×·¡Çǹý (Ûö)
  • Bradford method
    ºê·¡µåÆ÷µå ¹ý(Ûö)
  • catalytic exchange method
    Ã˸ű³È¯¹ý(õºØÚÎßüµÛö)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • transfrontal method
    °æÀüµÎ¹æ¹ý
  • transmission method
    Åõ°ú¹ý
  • uniform insonation method
    ±ÕµîÀ½ÆÄÁ¶»ç¹ý
  • water filled method
    ¹°Ã游¹ý
  • Zebra-stripe imaging method
    ¾ó·è¸»¹«´Ì¿µ»ó¹æ¹ý
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
A/G ratio Albumin/Globulin ratio; ¾ËºÎ¹Î´ë ±Û·ÎºÒ¸°ÀÇ ºñÀ²
S/D ratio Systolic / Diastolic ratio
C/N carbon/nitrogen [ratio]; carrier/ noise [ratio]
DR degeneration reaction; delivery room; deoxyribose; diabetic retinopathy; diagnostic radiology; digit...
ER efficiency ratio; epigastric region; ejection rate; electroresection; emergency room; endoplasmic re...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
MDL method detection limit
D.C.C. dextran coated charcoal method
PAP peroxidase anti peroxidase method
PCR polimerase chain reaction method
SCAM substituted cysteine accessibility method
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • uptake ratio
    ¼·ÃëÀ²
  • ventilation perfusion ratio
    ȯ±âÀ²
  • W/P ratio
    È¥¼öºñ
    ¼®°íÀÇ ¿¬È­¿¡ »ç¿ëµÇ´Â ¹°ÀÇ ¾ç°ú ¼®°í ºÐ¸»ÀÇ ¹«°Ô ºñ.
  • activated sludge method
    Ȱ¼º ¿À´Ï¹ý
  • agar diffusion method
    ÇÑõ È®»ê¹ý, ÇÑõ³» È®»ê¹ý
    ÇÑõÀÇ °Ö ³»¿¡¼­ ħ°­¹ÝÀÀÀ» ÇàÇÏ´Â ¹æ¹ýÀ̰í 2Á¾ ÀÌ»óÀÇ Ç׿ø ¹× Ç×ü°¡ °ü¿©ÇÏ´Â ¹ÝÀÀÀ» »ó¼¼ÇÏ°Ô ºÐ¼®ÇÏ´Â °ÍÀÌ °¡´ÉÇÏ´Ù. ¹ÝÀÀ ÀÎÀÚÀÇ ¾î´À ÇÑÂÊÀ» ÇÑõ ³»¿¡ ³ì¿©µÎ°í ´Ù¸¥ ÀÎÀÚ¸¦ È®»ê½ÃŰ´Â ´Ü¼ø È®»ê¹ý°ú ÇÑõÀÇ Áß°£Ãþ°ú ¶³¾îÁ®¼­ Ç׿ø°ú Ç×ü¸¦ È®»ê½ÃŰ´Â 2Áß È®»ê¹ý, ±×¸®°í ¸é¿ª Àü±â ¿µµ¿ÀÌ ÀÖ´Ù.
  • alkaline phosphatase antialkaline phophatase method
    ¾ËÄ®¸®¼º Æ÷½ºÆÄŸÁ¦ Ç×¾ËÄ®¸®¼º Æ÷½ºÆÄŸÁ¦¹ý
  • aspirative-irrigation method
    È©ÀÎ ¼¼Ã´¹ý
  • Barber's method
    ¹Ù¾Æ¹ö ¹ý
    ¹Ì»ý¹°À» Çö¹Ì°æ¿¡¼­ ´Ü¸®ÇÏ´Â Á¶ÀÛ¹ý.
  • Barker's method
    ¹Ù¾ÆÄ¿¹ý
    Ƽ¿À½Ã¾È¿°°ú Á¦ 2Áú»ê öÀÇ È­ÇÕ¿¡ ÀÇÇÑ ºñ»ö¹ý.
  • bioassay method
    »ý¹°ÇÐÀû °ËÁ¤¹ý
  • candle jar method
    Ä­µé Àھƹý, Ä­µé ÀÚ¾Æ ¹è¾ç¹ý
  • carbol fuchsin method
    Ä«¸£º¼ Ǫũ½Å ¹ý
  • Charter's method
    Â÷ÅÍ ¹ý
    Ä©¼Ö »ç¿ë¹ýÀÇ Çϳª·Î, ¼ÖÀÌ Ä¡¾Æ¿Í Ä¡Àº¿¡ ´ëÇÏ¿© 45¡Æ·Î Ä¡°ü ÂÊÀ¸·Î ±â¿ï¾îÁö°Ô Çϸ鼭 ¼öÆòÀ» À¯Áö½ÃŰ°í ¼ÖÀÇ ¹ÝÀº Ä¡¾Æ¿¡ ±×¸®°í ¹ÝÀº Ä¡Àº¿¡ ÀÖµµ·Ï ÇÑ ´ÙÀ½, ¾ÆÁÖ ÀÛÀº ¿øÀ» ±×¸®´Â µíÇÑ Áøµ¿ ¿îµ¿À» Áָ鼭 ÇÏ´Â ¹æ¹ý. À½½Ä Â±â¿Í Ä¡°£¿¡ ¼ÖÀÌ µé¾î°¡°Ô µÇ¾î ¸¶»çÁö ¿ªÇÒµµ ÇÑ´Ù.
  • Chopper method
    Chopper ¹ý
  • column diffusion method
    ±âµÕ È®»ê ¹æ¹ý
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
ratio scale A scale that involves physical units and demonstrates their relations.
(05 Mar 2000)
ventilation-perfusion ratio The ratio of alveolar ventilation to simultaneous alveolar capillary blood flow in any part of the lung.
(12 Dec 1998)
ventilation/perfusion ratio The ratio of alveolar ventilation to simultaneous alveolar capillary blood flow in any part of the lung; because both ventilation and perfusion are expressed per unit volume of tissue and per unit time, which cancel, the units become liters of gas per liter of blood.
(05 Mar 2000)
mass-action ratio The ratio of the product of all of the product concentrations divided by the product of all of the reactant concentrations of a particular reaction; when the reaction has been completed (i.e., t = ∞), then this ratio is equal to the equilibrium constant.
(05 Mar 2000)
case fatality ratio The mortality rate of a disease, usually expressed per 100 cases.
(05 Mar 2000)
CD4:CD8 ratio The ratio of CD4 to CD8 cells. A common measure of immune system status that is around two in healthy individuals. The ratio of T-lymphocytes that express the CD4 antigen to those that express the CD8 antigen. This value is commonly assessed in the diagnosis and staging of diseases affecting the immune system including HIV infection.
(12 Dec 1998)
reproductive ratio <epidemiology> 1. Basic reproductive ratio , Ro , a dimensionless parameter which encapsulates the biological details of different transmission mechanisms. For microparasites, Ro , is defined as the average number of secondary cases of infection to which one primary case gives rise throughout its infectious period if introduced into a defined population consisting solely of susceptible individuals. For macroparasites, Ro , is the average number of female offspring (or just offspring in the case of hermaphroditic species) produced throughout the lifetime of a mature female parasite, which themselves achieve reproductive maturity in the absence of density-dependent constraints on the parasite establishment, survival or reproduction.
Also known as the basic reproduction rate, number.
2. Effective reproductive ratio , R , The number of secondary cases (microparasites) or female offspring (macroparasites) produced in a host population not consisting entirely of susceptible individuals (microparasites) or within which density dependent constraints limit parasite population growth (macroparasites). Under conditions of stable endemic infection, R=1.
(05 Dec 1998)
respiratory exchange ratio The ratio of the net output of carbon dioxide to the simultaneous net uptake of oxygen at a given site, both expressed as moles or STPD volumes per unit time; in the steady state, respiratory exchange ratio is equal to the respiratory quotient of metabolic processes.
(05 Mar 2000)
mendelian ratio The ratio of progeny with a particular phenotypes or genotypes expected in accordance with Mendel's law among the offspring of matings specified as to genotype or phenotype.
(05 Mar 2000)
M:E ratio The ratio of myeloid to erythroid precursors in bone marrow; normally it varies from 2:1 to 4:1; an increased ratio is found in infections, chronic myelogenous leukaemia, or erythroid hypoplasia; a decreased ratio may mean a depression of leukopoiesis or normoblastic hyperplasia depending on the overall cellularity of the bone marrow.
(05 Mar 2000)
grid ratio In a radiographic scatter-absorbing grid, the ratio of the height to the width of the gaps between lead strips; a higher grid ratio removes more scattered radiation but requires more careful X-ray tube positioning to avoid grid cutoff of the primary radiation beam.
(05 Mar 2000)
gyromagnetic ratio In nuclear magnetic resonance, the ratio of the magnetic dipole moment of the nucleus to the nuclear spin angular momentum; the gyromagnetic ratio is a unique value for each type of nucleus.
Synonym: magnetogyric ratio.
(05 Mar 2000)
molecular weight ratio The sum of the atomic weight's of all the atoms constituting a molecule; the mass of a molecule relative to the mass of a standard atom, now 12C (taken as 12.000). Relative molecular mass (Mr) is the mass relative to the dalton and has no units.
See: atomic weight.
Synonym: molecular mass, molecular weight ratio, relative molecular mass.
(05 Mar 2000)
P/O ratio A measure of oxidative phosphorylation; the ratio of phosphate radicals esterified (forming adenosine 5'-triphosphate from adenosine 5'-diphosphate) to atoms of oxygen consumed by mitochondria; normally, the ratio is 3 (starting from NADH).
Synonym: P/O quotient.
(05 Mar 2000)
hand ratio The ratio of the length of the hand (measured on the dorsum from the styloid process of the ulna to the tip of the third finger) to the width across the knuckles.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 7 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • payout ratio
    ¹è´ç ¼ºÇâ
  • priceearnings ratio
    ÁÖ°¡ ¼öÀÍ·ü 9
  • project method
    ±¸¾È ±³¼ö¹ý(ÇлýÀÇ µÎ³ú Ȱµ¿°ú ÀÛ¾÷À» ¿ä±¸ÇÏ´Â ½Ç¹° ±³¼ö)
  • ratio
    ºñ;ºñÀ²
  • respiratory quotient (ratio)
    È£Èí·ü;È£Èíºñ(³»¹ñ´Â ź»ê°¡½ºÀÇ ¾ç°ú ¿ÜºÎ·ÎºÎÅÍ Èí¼öÇÏ´Â »ê¼Ò·®°úÀÇ ºñ)
  • rhythm method
    ÁÖ±â ÇÇÀÓ¹ý 6
  • risk-benefit ratio
    À§Ç輺°ú ¼öÀͼº°úÀÇ ºñÀ²
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
ÅëÇÕ°Ë»ö ¿Ï·á